Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Israel Daily Voice.
Press releases published on April 7, 2025
PainReform Provides Year-End Business Update
GlobeNewswire
·
April 7, 2025
TEL AVIV, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of the DeepSolar …
AMMWEC & Muslim Women Speakers Join Muslims Israel Dialogue for a Historic Gathering Promoting Peace & Healing
EIN Presswire
·
April 7, 2025
WASHINGTON DC, DC, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- Former Hostages, Muslim Leaders, and Interfaith Allies to Unite in New York City for Historic Gathering Promoting Peace and Healing On April 9, 2025, nine former Israeli hostages— …
Rail Vision Announces Participation in the LD Micro Invitational XV
GlobeNewswire
·
April 7, 2025
Ra’anana, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, announced today …
Inspira Technologies Announces Successful Treatment of First Patient with INSPIRA ART100 at Westchester Medical Center
GlobeNewswire
·
April 7, 2025
RA'ANANA, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced the successful completion of …
Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
GlobeNewswire
·
April 7, 2025
EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia gravis in adults who are anti-acetylcholine …
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
GlobeNewswire
·
April 7, 2025
If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in pediatric patients, addressing the high unmet need for …
Gilat Awarded Up to $23 Million Multi-Year Contract to Service Satellite Transportable Terminal Units for US DoD Customers
GlobeNewswire
·
April 7, 2025
PETAH TIKVA, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that Gilat Defense was awarded a contract to …